🇺🇸 E7080 capsule in United States

E7080 capsule (E7080 capsule) regulatory status in United States.

Marketing authorisation

FDA

  • Application: ANDA213092
  • Marketing authorisation holder: SUN PHARM INDS INC
  • Local brand name: LENVATINIB
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

E7080 capsule in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is E7080 capsule approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for E7080 capsule in United States?

SUN PHARM INDS INC holds the US marketing authorisation.